Repealed.
(Feb. 22, 2014, D.C. Law 20-66, § 4a; as added Apr. 11, 2019, D.C. Law 22-288, § 401(a), 66 DCR 1656; June 24, 2020, D.C. Law 23-116, § 4(a), 67 DCR 5081.)
For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see § 7168 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964).
For temporary (90 days) repeal of applicability provision of D.C. Law 22-288, see § 7168 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497).
Structure District of Columbia Code
Chapter 8G - Prescription Drug Monitoring
§ 48–853.02. Program establishment; Director’s authority
§ 48–853.03. Reporting requirements; exceptions
§ 48–853.03a. Registration requirement for prescribers and dispensers. [Repealed]
§ 48–853.03b. Registration requirement for practitioners and dispensers
§ 48–853.03c. Database Query requirement for prescribers and dispensers
§ 48–853.04. Authority to access database
§ 48–853.06. Interoperability; information exchange with other prescription drug monitoring programs
§ 48–853.08. Immunity from liability
§ 48–853.09. Unlawful disclosure of information and acts; disciplinary action authorized; penalties